Chemoembolization With or Without Antiviral Therapy for Unresectable HBV-related HCC With Low HBV DNA Replication
NCT01894269
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
200
Enrollment
OTHER
Sponsor class
Conditions
Hepatocellular Carcinoma
Interventions
DRUG:
Lamivudine 100mg once daily; or Entecavir 0.5mg once daily.
Sponsor
Sun Yat-sen University